RxDoctor Payments Data

Harmony Allison, MD

Gastroenterology · Boston, MANPI 1245240704

Payments from drug & device makers

$29,867in general payments, 2019–2025

Across 30 payments — averaging $995.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$29K
  • Medtronic$795
  • AbbVie$347
  • Johnson & Johnson$134
  • Sanofi$39
  • Pfizer$23

What the payments were for

  • Travel & lodging$77158%
  • Food & beverage$56742%

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron4$28,528
Medtronic4$795
AbbVie18$347
Johnson & Johnson(2 entities)2$134
Sanofi1$39
Pfizer1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,867 in reported general payments places this provider in the 80th percentile of 579 gastroenterology providers in Massachusetts.

See all gastroenterology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$57,471
Medicare patients
266
Services billed
462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase11$56,515
LinzessLinaclotide60$50,921
RelistorMethylnaltrexone Bromide11$26,548
MotegrityPrucalopride Succinate30$17,383
Mesalamine18$16,496
TrulancePlecanatide12$10,085
Dexlansoprazole DrDexlansoprazole32$6,095
Famotidine67$5,523
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl114$1,665
Colestipol Hcl14$1,573
Omeprazole82$1,568
Pantoprazole Sodium54$901
Rabeprazole Sodium15$895
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl47$800
Cyproheptadine Hcl12$738

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$347$107,43671 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 579 gastroenterology providers in Massachusetts.

Other gastroenterology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →